一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> ACS Applied Electronic Materials >>article
ACS Applied Electronic Materials

ACS Applied Electronic Materials

IF: 4.3
Download PDF

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Published:18 August 2020 DOI: 10.3389/frai.2020.00065 PMID: 33733182
Arash Keshavarzi Arshadi,?Julia Webb,?Milad Salem,?Emmanuel Cruz,?Stacie Calad-Thomson,?Niloofar Ghadirian,?Jennifer Collins,?Elena Diez-Cecilia,?Brendan Kelly,?Hani Goodarzi,?Jiann Shiun Yuan

Abstract

SARS-COV-2 has roused the scientific community with a call to action to combat the growing pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved vaccines available for deployment as a frontline defense. Understanding the pathobiology of COVID-19 could aid scientists in their discovery of potent antivirals by elucidating unexplored viral pathways. One method for accomplishing this is the leveraging of computational methods to discover new candidate drugs and vaccines in silico. In the last decade, machine learning-based models, trained on specific biomolecules, have offered inexpensive and rapid implementation methods for the discovery of effective viral therapies. Given a target biomolecule, these models are capable of predicting inhibitor candidates in a structural-based manner. If enough data are presented to a model, it can aid the search for a drug or vaccine candidate by identifying patterns within the data. In this review, we focus on the recent advances of COVID-19 drug and vaccine development using artificial intelligence and the potential of intelligent training for the discovery of COVID-19 therapeutics. To facilitate applications of deep learning for SARS-COV-2, we highlight multiple molecular targets of COVID-19, inhibition of which may increase patient survival. Moreover, we present CoronaDB-AI, a dataset of compounds, peptides, and epitopes discovered either in silico or in vitro that can be potentially used for training models in order to extract COVID-19 treatment. The information and datasets provided in this review can be used to train deep learning-based models and accelerate the discovery of effective viral therapies.

Similar articles

IF:4.2

Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic

European journal of pharmacology Sobia Noreen, Irsah Maqbool,etc Published: 5 March 2021
IF:4.7

Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19.

Infectious Diseases and Therapy Takahiro Takazono,?Satoki Fujita,etc Published: 1 August 2024
IF:7.6

Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial

The Lancet Regional Health: Western Pacific Fuxiang Wang , Wen Xiao ,etc Published: 1 September 2023
根河市| 连州市| 章丘市| 高陵县| 东平县| 天门市| 阳东县| 长岛县| 象州县| 儋州市| 虹口区| 康保县| 平泉县| 格尔木市| 杂多县| 山丹县| 会泽县| 浠水县| 淳安县| 阳泉市| 洛南县| 临海市| 绿春县| 南京市| 内乡县| 湟源县| 祁东县| 蒙山县| 黄大仙区| 荣成市| 南澳县| 密云县| 武宣县| 澄江县| 石阡县| 营山县| 大荔县| 博乐市| 高雄市| 天祝| 务川|